Latest filing published 12 Jul 2023 for Sensei Biotherapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Bob Holmen: trading record in brief
Bob Holmen, listed as board member, appears in our data through filings on Faeth Therapeutics, Inc. shares, published by SEC (Form 4). Between 10 June 2022 and 10 July 2023, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 12 July 2023 came the latest disclosure, a share grant in Faeth Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bob Holmen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,466 shares0Common StockSEC:0001209191-23-042095:0
- 4,466 shares0Common StockSEC:0001209191-22-036665:0
2 of 2 declarations
